InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Goldstein Dov A Md, 董事. Director active across 4 companies, notably NeuBase Therapeutics, Inc.. Cumulatively, 10 disclosures have been logged. Split: 2 buys · 1 sell. Total volume traded: €32k. Activity tracked since 18 June 2021. The latest transaction was filed on 23 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Goldstein Dov A Md
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
3,542 股@ US$4.380.0014% mcap100.0% 占其流量Common StockSEC:0001120478-26-000013:0
3,542 股@ US$4.385.3% 占其流量Common StockSEC:0001120478-26-000011:0
3,541 股@ US$4.385.2% 占其流量Common StockSEC:0001120478-26-000007:0
3,542 股@ US$4.385.4% 占其流量Common StockSEC:0001120478-26-000005:0
27,000 股@ US$8.3978.6% 占其流量Common StockSEC:0001120478-26-000003:0
17,557 股@ US$1.09100.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001641172-25-024820:0
10,000 股Common Stock, par value $0.0001 per shareSEC:0001493152-23-000221:0
标准退出：2023年4月3日 (T+90)
8,000 股@ US$4.75100.0% 占其流量Common StockSEC:0001104659-21-083253:0
标准退出：2021年9月16日 (T+90)
842 股Common StockSEC:0000950142-16-002788:0
842 股Common StockSEC:0000950142-16-002788:1
10 条申报中的 10 条
About Goldstein Dov A Md
Administrateur, GOLDSTEIN DOV A MD has 10 filings in total. Across the 10 recent sampled filings, the period runs from 2016-01-06 to 2026-04-24, with buys of EUR 31897 and no sells, and the most common transaction type is option exercise. He is linked to BioAge Labs, Inc., Coya Therapeutics, Inc., CEMPRA, INC., and NeuBase Therapeutics, Inc.
